John C. Browning, MD, MBA; Carolyn Enloe, MPH; Martina Cartwright, PhD; et al.
open access
JAMA Dermatol. 2022;158(8):871-878. doi:10.1001/jamadermatol.2022.2721
This multicenter, vehicle-controlled, double-blind, phase 3 randomized clinical trial examined the clearance rates of molluscum contagiosum and adverse events of berdazimer gel, 10.3%, for patients 6 months and older during 12 weeks.
Anna L. Chien, MD; Daniel J. Kim, PhD; Nancy Cheng, MD; et al.
free access
JAMA Dermatol. 2022;158(8):879-886. doi:10.1001/jamadermatol.2022.1891
This randomized clinical trial evaluates the clinical efficacy of topical tretinoin precursors and tretinoin in treating moderate to severe facial photodamage and identifies potential biomarkers that correlate with clinical efficacy.
Rawaan Elsawi, BHSc; Katie Dainty, PhD; Wendy Smith Begolka, MBS; et al.
open access
JAMA Dermatol. 2022;158(8):887-892. doi:10.1001/jamadermatol.2022.1906
This survey study examines the associations between demographic and clinical variables and patient-reported overall burden of atopic dermatitis among mainly US adults.
Alexandre Lemieux, MD; Maud Maho-Vaillant, PhD; Marie-Laure Golinski, PhD; et al.
free access
JAMA Dermatol. 2022;158(8):893-899. doi:10.1001/jamadermatol.2022.2149
This cohort study examines the prevalence of antirituximab antibodies in patients with pemphigus who are treated with rituximab and their association with complete remission and relapse.
Zachary H. Hopkins, MD; Diane Thiboutot, MD; Haya A. Homsi, MD, MPH; et al.
free access
JAMA Dermatol. 2022;158(8):900-911. doi:10.1001/jamadermatol.2022.2260
This systematic review evaluates the standards of evidence used in patient-reported outcome measures assessing health-related quality of life for patients with acne.
Isabelle J. Thibau, MPH; Allison R. Loiselle, PhD; Emile Latour, MS; et al.
open access
JAMA Dermatol. 2022;158(8):912-918. doi:10.1001/jamadermatol.2022.2441
This survey study characterizes the experiences, preferences, and expectations for shared decision-making in eczema care settings from the patient and caregiver perspective.